Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$98.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 15,114 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 20,853 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 11,250 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 6,250 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 16,150 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 9,444 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 4,156 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 2,406 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 8,075 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 8,075 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 16,150 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 16,150 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 8,394 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 8,394 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 5,625 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 5,625 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 65,955 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 28 | APLS | Apellis Pharmaceuticals,… | AGRANT | 16,150 | — | — | +32.4% | Open the original filing on SEC.gov |
| Jan 22 | APLS | Apellis Pharmaceuticals,… | SSELL | 2,064 | $21.77 | $44.9K | -4.0% | Open the original filing on SEC.gov |
| Jan 20 | APLS | Apellis Pharmaceuticals,… | SSELL | 726 | $19.79 | $14.4K | -1.4% | Open the original filing on SEC.gov |
| Jan 13 | APLS | Apellis Pharmaceuticals,… | SSELL | 873 | $22.19 | $19.4K | -1.6% | Open the original filing on SEC.gov |
| Sep 15, 2025 | APLS | Apellis Pharmaceuticals,… | SSELL | 189 | $24.19 | $4.6K | -0.4% | Open the original filing on SEC.gov |
| Sep 2, 2025 | APLS | Apellis Pharmaceuticals,… | SSELL | 548 | $28.08 | $15.4K | -1.0% | Open the original filing on SEC.gov |
| Jun 18, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT | 6,250 | — | — | +13.0% | Open the original filing on SEC.gov |
| Jun 9, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 11,250 | $19.39 | $218.1K | — | Open the original filing on SEC.gov |